Back to Journals » OncoTargets and Therapy

OncoTargets and Therapy

ISSN: 1178-6930

Editor-in-Chief: Professor Gaetano Romano

OncoTargets and Therapy is an international, peer-reviewed journal focusing on the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer. This journal explores the evidence behind new and existing therapies to aid their informed acceptance by clinicians and treatment adherence by patients.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Latest articles:

- 5 records -

Diffuse Large B-Cell Lymphoma (DLBCL): Early Patient Management and Emerging Treatment Options

Vodicka P, Klener P, Trneny M

OncoTargets and Therapy 2022, 15:1481-1501

Published Date: 6 December 2022

Licorice (Glycyrrhiza glabra L.)-Derived Phytochemicals Target Multiple Signaling Pathways to Confer Oncopreventive and Oncotherapeutic Effects

Tuli HS, Garg VK, Mehta JK, Kaur G, Mohapatra RK, Dhama K, Sak K, Kumar A, Varol M, Aggarwal D, Anand U, Kaur J, Gillan R, Sethi G, Bishayee A

OncoTargets and Therapy 2022, 15:1419-1448

Published Date: 30 November 2022

Successful Targeting of CTLA-4 in a Melanoma Clinical Case: A Long-Term “One Stop Therapeutic Shop”

Colucci M, D'Alonzo V, Santangelo F, Miracco C, Valente M, Maio M, Di Giacomo AM

OncoTargets and Therapy 2022, 15:1409-1415

Published Date: 25 November 2022

Read more articles